新光药业: 2024年年度权益分派实施公告

Core Viewpoint - Zhejiang Xinguang Pharmaceutical Co., Ltd. has announced its 2024 annual profit distribution plan, which includes a cash dividend of RMB 3.00 per share, totaling RMB 48 million, approved by the shareholders' meeting on May 13, 2025 [1][2]. Summary by Sections Profit Distribution Plan - The profit distribution plan involves a cash dividend of RMB 3.00 per 10 shares, amounting to a total cash distribution of RMB 48 million (including tax) [1]. - No capital reserve will be converted into share capital, and no bonus shares will be issued. The remaining undistributed profits will be carried forward to future years [1]. Dividend Taxation - For Hong Kong market investors, QFII, RQFII, and individual investors holding pre-IPO restricted shares, the cash dividend will be RMB 2.70 per 10 shares after tax [1]. - A differentiated tax rate will apply for individual shareholders based on their holding period when transferring shares, with specific tax amounts outlined for different holding durations [2]. Key Dates - The record date for the dividend distribution is set for May 27, 2025, and the ex-dividend date is May 28, 2025 [2]. Distribution Method - The cash dividends will be directly credited to the shareholders' accounts through their securities companies or other custodians [2]. - The company assumes all legal responsibilities for any shortfall in cash dividends due to a decrease in shares held by shareholders during the distribution application period [2].